Who
David Dornan
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Whitehawk Therapeutics; Chief Scientific Officer, Elevation Oncology; Chief Scientific Officer, Bolt Biotherapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 4 Feb 2021
- Last trade
- 15 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,887 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —282,340 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —282,340 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —687,979 at $0.00 | filing |
| 15 Feb 2025filed 19 Feb 2025 | Elevation Oncologyoption or derivative | SEC FORM 4 Code M | —9,375 at $0.00 | filing |
| 15 Feb 2025filed 19 Feb 2025 | Elevation Oncology | SEC FORM 4 Code M | —9,375 | filing |
| 15 Feb 2025filed 19 Feb 2025 | Elevation Oncology | SEC FORM 4 Code F | $2,7824,152 at $0.67 | filing |
| 15 Feb 2024filed 20 Feb 2024 | Elevation Oncologyoption or derivative | SEC FORM 4 Code A | —225,000 at $0.00 | filing |
| 15 Feb 2024filed 20 Feb 2024 | Elevation Oncologyoption or derivative | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | Elevation Oncologyoption or derivative | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 6 Jan 2023filed 10 Jan 2023 | Elevation Oncologyoption or derivative | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 14 Mar 2022filed 16 Mar 2022 | Elevation Oncologyoption or derivative | SEC FORM 4 Code A | —230,000 at $0.00 | filing |
| 18 Feb 2022filed 23 Feb 2022 | BOLT Bolt Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.